EN PL

EMA: European Medicines Agency explores ways to further involve patients in the benefit-risk assessment of medicines

31.10.2013
The European Medicines Agency has published a report of the workshop held on 26 September 2013 to discuss further development of patient involvement in the evaluation of medicines, in particular in the assessment of benefit and risk that lies at the heart of the regulatory process.